Business Standard

Dr Reddys Laboratories launches Pyrimethamine Tablets

Image

Capital Market
Dr Reddys Laboratories announced the launch of Pyrimethamine Tablets USP, 25 mg, a therapeutic equivalent and first-wave generic version of Daraprim (pyrimethamine) Tablets, approved by the U.S. Food and Drug Administration (USFDA). This product is the only AB-rated generic version Daraprim (pyrimethamine) Tablets approved by the USFDA.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 20 2020 | 9:12 AM IST

Explore News